News
-
-
-
PRESS RELEASE
EQS-Adhoc: Siltronic AG: Siltronic AG launches cash capital increase from authorized share capital with exclusion of shareholders’ subscription rights through accelerated bookbuilding
Siltronic AG launches cash capital increase from authorized share capital with exclusion of shareholders’ subscription rights through accelerated bookbuilding on June 15, 2026 -
PRESS RELEASE
Carvolix announces positive 3-years clinical results for Kalios™ , the only adjustable mitral ring. 100% of patients met primary endpoint for mitral regurgitation.
Carvolix announces positive 3-year clinical results for Kalios™, the adjustable mitral ring, with 100% of patients meeting primary endpoint for mitral regurgitation. Company plans FDA submission in 2027 -
-
-
-
-
REGULATED PRESS RELEASE
Disclosure of transactions in own shares from June 8 to June 12, 2026
-